Skip to main content Skip to section navigation Skip to footer
Investors & Media Clinical Trials Careers Contact Us
Facebook link Twitter link Linkedin link
CymaBay Therapeutics
  • Home
  • Our Company
    • Overview
    • Leadership Team
    • Board of Directors
  • Our Purpose
    • Overview
    • About Liver Disease
    • About PBC
    • Patient Advocacy
    • Patient Resources
    • Grants & Giving
    • Expanded Access
  • Our Science
    • Overview
    • Unmet Needs in PBC
    • Seladelpar
    • MBX-2982
    • Collaborations
  • Investors & Media
  • Clinical Trials
  • Careers
  • Contact Us

Press Releases

Investors & Media

Investors & Media

  • Overview
  • News & Events
    • Overview
    • Press Releases
    • IR Calendar
    • Presentations
    • Publications
    • Email Alerts
  • Company Info
    • Overview
    • Leadership Team
    • Contacts
    • FAQ
  • Financial Info
    • Overview
    • Financial Results
    • Income Statement
    • Balance Sheet
    • Cash Flow
  • Stock Data
    • Quote
    • Charts
    • Historical Data
    • Analyst Coverage
  • SEC Filings
    • Overview
    • All SEC Filings
    • Annual Reports
    • Quarterly Reports
    • Section 16 Filings
  • Governance
    • Overview
    • Board of Directors
    • Board Committees
    • Governance Documents
  • News & Events

  • Overview
  • Press Releases
  • IR Calendar
  • Presentations
  • Publications
  • Email Alerts
Jun 19, 2020 8:00 am EDT

CymaBay Therapeutics Presents Data at Digestive Disease Week 2020 Online Education

Jun 05, 2020 5:00 pm EDT

Notice of Change of Location of Annual Meeting of Stockholders to be Held on June 23, 2020

May 11, 2020 4:01 pm EDT

CymaBay Reports First Quarter 2020 Financial Results and Provides Corporate Update

May 04, 2020 4:43 pm EDT

CymaBay Therapeutics to Report First Quarter 2020 Financial Results on Monday, May 11

Mar 13, 2020 5:29 pm EDT

CymaBay Therapeutics Comments on Engine Capital Director Nominations

Mar 12, 2020 4:01 pm EDT

CymaBay Reports Fourth Quarter and Fiscal Year End 2019 Financial Results and Provides Corporate Update

Mar 05, 2020 4:01 pm EST

CymaBay Therapeutics to Report Fourth Quarter and Full Year 2019 Financial Results on Thursday, March 12

Jan 29, 2020 4:15 pm EST

CymaBay Publishes Shareholder Letter

Nov 25, 2019 8:00 am EST

CymaBay Therapeutics Halts Clinical Development of Seladelpar

Nov 14, 2019 8:00 am EST

CymaBay Therapeutics to Present at Upcoming Investor Conferences

  • Previous Pagearrow_back
  • Page 1
  • …
  • Page 5
  • Page 6
  • Page 7
  • Page 8
  • Page 9
  • Page 10
  • Page 11
  • Page 12
  • Page 13
  • Page 14
  • …
  • …Page 28
  • Next Pagearrow_forward
rss_feed News RSS
  • Email Alerts
  • Company Profile
  • Contacts
  • RSS News Feed
©2023 CymaBay Therapeutics. All Rights Reserved.
Privacy Policy Disclaimer Sitemap Manage Cookie Preferences
Facebook link Twitter link Linkedin link

You are leaving our website!

Continue